These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11922956)

  • 1. Computer systems for the prediction of toxicity: an update.
    Greene N
    Adv Drug Deliv Rev; 2002 Mar; 54(3):417-31. PubMed ID: 11922956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Commission for Protection Against Environmental Mutagens and Carcinogens. Approaches to SAR in carcinogenesis and mutagenesis. Prediction of carcinogenicity/mutagenicity using MULTI-CASE.
    Klopman G; Rosenkranz HS
    Mutat Res; 1994 Feb; 305(1):33-46. PubMed ID: 7508546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Commission for Protection Against Environmental Mutagens and Carcinogens. Use of SAR in computer-assisted prediction of carcinogenicity and mutagenicity of chemicals by the TOPKAT program.
    Enslein K; Gombar VK; Blake BW
    Mutat Res; 1994 Feb; 305(1):47-61. PubMed ID: 7508547
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure-activity relations: maximizing the usefulness of mutagenicity and carcinogenicity databases.
    Klopman G; Rosenkranz H
    Environ Health Perspect; 1991 Dec; 96():67-75. PubMed ID: 1820281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer systems for the prediction of xenobiotic metabolism.
    Langowski J; Long A
    Adv Drug Deliv Rev; 2002 Mar; 54(3):407-15. PubMed ID: 11922955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of computational analysis as a sentinel tool in toxicological assessments.
    Pearl GM; Livingston-Carr S; Durham SK
    Curr Top Med Chem; 2001 Sep; 1(4):247-55. PubMed ID: 11899110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole: an exploration of its reported genotoxicity.
    Rosenkranz HS; Klopman G
    Mutagenesis; 1991 Sep; 6(5):381-4. PubMed ID: 1795642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Learning rules to predict rodent carcinogenicity of non-genotoxic chemicals.
    Lee Y; Buchanan BG; Mattison DM; Klopman G; Rosenkranz HS
    Mutat Res; 1995 May; 328(2):127-49. PubMed ID: 7739598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the potential for genotoxic carcinogenicity of fragrances and other chemicals.
    Rosenkranz HS; Zhang YP; Klopman G
    Food Chem Toxicol; 1998 Aug; 36(8):687-96. PubMed ID: 9734719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternatives to the carcinogenicity bioassay for toxicity prediction: are we there yet?
    Benigni R
    Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):407-17. PubMed ID: 22360376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of predictivity of volatile organic compounds carcinogenicity and mutagenicity by freeware in silico models.
    Guerra LR; de Souza AMT; Côrtes JA; Lione VOF; Castro HC; Alves GG
    Regul Toxicol Pharmacol; 2017 Dec; 91():1-8. PubMed ID: 28970106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Commission for Protection Against Environmental Mutagens and Carcinogens. Application of SAR methods to non-congeneric data bases associated with carcinogenicity and mutagenicity: issues and approaches.
    Richard AM
    Mutat Res; 1994 Feb; 305(1):73-97. PubMed ID: 7508549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New perspectives in toxicological information management, and the role of ISSTOX databases in assessing chemical mutagenicity and carcinogenicity.
    Benigni R; Battistelli CL; Bossa C; Tcheremenskaia O; Crettaz P
    Mutagenesis; 2013 Jul; 28(4):401-9. PubMed ID: 23470317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships for the mutagenicity and carcinogenicity of simple and alpha-beta unsaturated aldehydes.
    Benigni R; Passerini L; Rodomonte A
    Environ Mol Mutagen; 2003; 42(3):136-43. PubMed ID: 14556221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative structure-activity relationships for predicting mutagenicity and carcinogenicity.
    Patlewicz G; Rodford R; Walker JD
    Environ Toxicol Chem; 2003 Aug; 22(8):1885-93. PubMed ID: 12924587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of genetic toxicology in drug discovery and optimization.
    Custer LL; Sweder KS
    Curr Drug Metab; 2008 Nov; 9(9):978-85. PubMed ID: 18991595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Salmonella mutagenicity.
    Zeiger E; Ashby J; Bakale G; Enslein K; Klopman G; Rosenkranz HS
    Mutagenesis; 1996 Sep; 11(5):471-84. PubMed ID: 8921509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based methods for predicting mutagenicity and carcinogenicity: are we there yet?
    Richard AM
    Mutat Res; 1998 May; 400(1-2):493-507. PubMed ID: 9685707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The OSIRIS Weight of Evidence approach: ITS mutagenicity and ITS carcinogenicity.
    Buist H; Aldenberg T; Batke M; Escher S; Klein Entink R; Kühne R; Marquart H; Pauné E; Rorije E; Schüürmann G; Kroese D
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):170-81. PubMed ID: 23357514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.